e-learning
resources
Vienna 2012
Monday, 03.09.2012
MS3 Update in idiopatic pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Advances in the therapeutical management of IPF
L. Richeldi (Modena, Italy)
Source:
Annual Congress 2012 - MS3 Update in idiopatic pulmonary fibrosis
Session:
MS3 Update in idiopatic pulmonary fibrosis
Session type:
Morning Seminar
Number:
1602
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Richeldi (Modena, Italy). Advances in the therapeutical management of IPF. Annual Congress 2012 - MS3 Update in idiopatic pulmonary fibrosis
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Advances in COPD management
Source: International Congress 2015 – China Day "Advances in pulmonology" I
Year: 2015
Advances in the diagnostic approach to sarcoidosis
Source: Annual Congress 2013 –ERS/JAMA Lunchtime session "Advances in IPF, bronchiectasis and sarcoidosis"
Year: 2013
Some advances in COPD treatment and management
Source: Eur Respir J 2004; 24: Suppl. 48, 85s
Year: 2004
Perspectives of therapeutic innovation from current progress in the pathobiology of pulmonary hypertension
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020
Impact of diagnostic pitfalls on the management of pulmonary sarcoidosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012
Current strategies for managing CTEPH
Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension
Year: 2021
Clinical implications of the new concepts regarding COPD pathophysiology
Source: Annual Congress 2008 - New insights into COPD pathophysiology
Year: 2008
Current surgical management of bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 626s
Year: 2004
Combining therapeutical options in CTEPH
Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension
Year: 2018
Bronchiectasis: state-of-the-art diagnostic and therapeutic approaches
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021
Early diagnostics of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 515s
Year: 2004
Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis
Year: 2010
Developments in the management and treatment of pulmonary embolism
Source: Eur Respir Rev 2015; 24: 484-497
Year: 2015
Current understanding of ARDS pathophysiology
Source: Virtual Congress 2021 – Acute respiratory distress syndrome phenotypes: implications for diagnosis and treatment
Year: 2021
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials
Source: Eur Respir J 2015; 46: 243-249
Year: 2015
Advances in pleural disease
Source: Eur Respir Rev 2016; 25: 108-109
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept